Exploitation of cellular signaling and regulatory pathways by human cytomegalovirus

Trends in Microbiology

Volumn 8, Issue 3, 2000, Pages 111-119

  Fortunato, Elizabeth A ^a   McElroy, Anita K ^a   Sanchez, Veronica ^a   Spector, Deborah H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIRTH DEFECT; CELL CYCLE; CELL MEMBRANE; CYTOMEGALOVIRUS INFECTION; HUMAN; HUMAN CYTOMEGALOVIRUS; IMMUNE RESPONSE; MORBIDITY; MORTALITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; VIRUS ADSORPTION; VIRUS CELL INTERACTION;

CELL CYCLE; CYTOMEGALOVIRUS; HUMANS; INTERFERONS; MITOGEN-ACTIVATED PROTEIN KINASES; SIGNAL TRANSDUCTION;

CYTOMEGALOVIRUS; DNA VIRUSES; HUMAN HERPESVIRUS 5;

EID: 0034161955     PISSN: 0966842X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-842X(00)01699-1     Document Type: Review

References (73)

1. Mocarski E.S. Cytomegaloviruses and their replication. Fields B.N.et al. Field's Virology. 1996;2447-2492 Lippincott-Raven.
2. Britt W., Alford C. Cytomegalovirus. Fields B.N.et al. Field's Virology. 1996;2493-2523 Lippincott-Raven.
3. Zhou Y.F.et al. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. New Engl. J. Med. 335:1996;624-630.
4. Topilko A., Michelson S. Hyperimmediate entry of human cytomegalovirus virions and dense bodies into human fibroblasts. Res. Virol. 145:1994;75-82.
5. Fortunato E.A., Spector D.H. Regulation of human cytomegalovirus gene expression. Adv. Virus Res. 54:1999;61-128.
6. Albrecht T.et al. Metabolic and cellular effects of human cytomegalovirus infection. Transplant. Proc. 23:1991;48-55.
7. Speir E.et al. Role of reactive oxygen intermediates in cytomegalovirus gene expression and in the response of human smooth muscle cells to viral infection. Circ. Res. 79:1996;1143-1152.
8. Shibutani T.et al. Pertussis toxin-sensitive G proteins as mediators of the signal transduction pathways activated by cytomegalovirus infection of smooth muscle cells. J. Clin. Invest. 100:1997;2054-2061.
9. Speir E.et al. Aspirin attenuates cytomegalovirus infectivity and gene expression mediated by cyclooxygenase-2 in coronary artery smooth muscle cells. Circ. Res. 83:1998;210-216.
10. Zhu H.et al. Use of differential display analysis to assess the effect of human cytomegalovirus infection on the accumulation of cellular RNAs: induction of interferon-responsive RNAs. Proc. Natl. Acad. Sci. U. S. A. 94:1997;13985-13990.
11. Zhu H.et al. Cellular gene expression altered by human cytomegalovirus: global monitoring with oligonucleotide arrays. Proc. Natl. Acad. Sci. U. S. A. 95:1998;14470-14475.
12. Ishov A.M.et al. Human cytomegalovirus immediate early interaction with host nuclear structures: definition of an immediate transcript environment. J. Cell Biol. 138:1997;5-16.
13. Ahn J.H., Hayward G.S. The major immediate-early proteins IE1 and IE2 of human cytomegalovirus co-localize with and disrupt PML-associated nuclear bodies at very early times in infected permissive cells. J. Virol. 71:1997;4599-4613.
14. Ahn J.H.et al. Disruption of PML subnuclear domains by the acidic IE1 protein of human cytomegalovirus is mediated through interaction with PML and may modulate a RING finger-dependent cryptic transactivator function of PML. Mol. Cell. Biol. 18:1998;4899-4913.
15. Wilkinson G.W.et al. Disruption of PML-associated nuclear bodies mediated by the human cytomegalovirus major immediate early gene product. J. Gen. Virol. 79:1998;1233-1245.
16. Müller S., Dejean A. Viral immediate-early proteins abrogate the modification by SUMO-1 of PML and Sp100 proteins, correlating with nuclear body disruption. J. Virol. 73:1999;5139-5143.
17. Wang Z.G.et al. Role of PML in cell growth and the retinoic acid pathway. Science. 279:1998;1547-1551.
18. Zheng P.et al. Proto-oncogene PML controls genes devoted to MHC class I antigen presentation. Nature. 396:1998;373-376.
19. Doucas V.et al. Modulation of CREB-binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling. Proc. Natl. Acad. Sci. U. S. A. 96:1999;2627-2632.
20. Labbaye C.et al. Expression and role of PML gene in normal adult hematopoiesis: functional interaction between PML and Rb proteins in erythropoiesis. Oncogene. 18:1999;3529-3540.
21. Bresnahan W.A.et al. Human cytomegalovirus inhibits cellular DNA synthesis and arrests productively infected cells in late G1. Virology. 224:1996;150-160.
22. Dittmer D., Mocarski E.S. Human cytomegalovirus infection inhibits G1/S transition. J. Virol. 71:1997;1629-1634.
23. Jault F.M.et al. Cytomegalovirus infection induces high levels of cyclins, phosphorylated Rb and p53, leading to cell cycle arrest. J. Virol. 69:1995;6697-6704.
24. Lu M., Shenk T. Human cytomegalovirus infection inhibits cell cycle progression at multiple points, including the transition from G1 to S. J. Virol. 70:1996;8850-8857.
25. Salvant B.S.et al. Cell cycle dysregulation by human cytomegalovirus: influence of the cell cycle phase at the time of infection and effects on cyclin transcription. J. Virol. 72:1998;3729-3741.
26. Fortunato E.A.et al. Specific chromosome 1 breaks induced by human cytomegalovirus. Proc. Natl. Acad. Sci. U. S. A. 97:2000;853-858.
27. Rodems S.M., Spector D.H. Extracellular signal-regulated kinase activity is sustained early during human cytomegalovirus infection. J. Virol. 72:1998;9173-9180.
28. Liu F.et al. The human MYT1 kinase preferentially phosphorylates CDC2 on threonine 14 and localizes to the endoplasmic reticulum and Golgi complex. Mol. Cell. Biol. 17:1997;571-583.
29. Palmer A.et al. A link between MAP kinase and p34(CDC2)/cyclin B during oocyte maturation: p90(RSK) phosphorylates and inactivates the p34(CDC2) inhibitory kinase MYT1. EMBO J. 17:1998;5037-5047.
30. Harel N.Y., Alwine J.C. Phosphorylation of the human cytomegalovirus 86-kilodalton immediate-early protein IE2. J. Virol. 72:1998;5481-5492.
31. Billstrom M.A.et al. Intracellular signaling by the chemokine receptor US28 during human cytomegalovirus infection. J. Virol. 72:1998;5535-5544.
32. Muganda P.et al. Human cytomegalovirus elevates levels of the cellular protein p53 in infected fibroblasts. J. Virol. 68:1994;8028-8034.
33. Speir E.et al. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science. 265:1994;391-394.
34. Fortunato E.A., Spector D.H. p53 and RPA are sequestered in viral replication centers in the nuclei of cells infected with human cytomegalovirus. J. Virol. 72:1998;2033-2039.
35. Bonin L.R., McDougall J.K. Human cytomegalovirus IE2 86-kilodalton protein binds p53 but does not abrogate G1 checkpoint function. J. Virol. 71:1997;5861-5870.
36. Tanaka K.et al. Effects of human cytomegalovirus immediate-early proteins on p53-mediated apoptosis in coronary artery smooth muscle cells. Circulation. 99:1999;1656-1659.
37. Bresnahan W.A.et al. Cyclin E/CDK2 activity is controlled by different mechanisms in the G0 and G1 phases of the cell cycle. Cell Growth Differ. 7:1996;1283-1290.
38. Bresnahan W.A.et al. Inhibition of cellular CDK2 activity blocks human cytomegalovirus replication. Virology. 231:1997;239-247.
39. Poma E.E.et al. The human cytomegalovirus IE1-72 protein interacts with the cellular p107 protein and relieves p107-mediated transcriptional repression of an E2F-responsive promoter. J. Virol. 70:1996;7867-7877.
40. Hagemeier C.et al. Functional interaction between the HCMV IE2 transactivator and the retinoblastoma protein. EMBO J. 13:1994;2897-2903.
41. Sommer M.H.et al. Transactivation by the human cytomegalovirus IE2 86 kDa protein requires a domain that binds to both TBP and RB. J. Virol. 68:1994;6223-6231.
42. Choi K.S.et al. The retinoblastoma gene product negatively regulates transcriptional activation mediated by the human cytomegalovirus IE2 protein. Virology. 208:1995;450-456.
43. Fortunato E.A.et al. Identification of domains within the human cytomegalovirus major immediate-early 86-kilodalton protein and the retinoblastoma protein required for physical and functional interaction with each other. J. Virol. 71:1997;8176-8185.
44. Bresnahan W.A.et al. The cyclin E promoter is activated by human cytomegalovirus 86-kDa immediate early protein. J. Biol. Chem. 273:1998;22075-22082.
45. Stark G.R.et al. How cells respond to interferons. Annu. Rev. Biochem. 67:1998;227-264.
46. Haque S.J.et al. Roles of protein-tyrosine phosphatases in STAT1 α-mediated cell signaling. J. Biol. Chem. 270:1995;25709-25714.
47. Li X.et al. Formation of STAT1-STAT2 heterodimers and their role in the activation of IRF-1 gene transcription by interferon-α J. Biol. Chem. 271:1996;5790-5794.
48. Navarro L.et al. Cytomegalovirus activates interferon immediate-early response gene expression and an interferon regulatory factor 3-containing interferon-stimulated response element-binding complex. Mol. Cell. Biol. 18:1998;3796-3802.
49. Boyle K.A.et al. Engagement of the cellular receptor for glycoprotein B of human cytomegalovirus activates the interferon-responsive pathway. Mol. Cell. Biol. 19:1999;3607-3613.
50. Miller D.M.et al. Human cytomegalovirus inhibits IFN α-stimulated antiviral and immunoregulatory responses by blocking multiple levels of IFN-α signal transduction. J. Immunol. 162:1999;6107-6113.
51. Sedmak D.D.et al. Cytomegalovirus inhibits major histocompatibility class II expression on infected endothelial cells. Am. J. Pathol. 144:1994;683-692.
52. Miller D.M.et al. Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the JAK/STAT pathway. J. Exp. Med. 187:1998;675-683.
53. + T-cell response is mediated by repression of γ interferon-induced class II transactivator expression. J. Virol. 73:1999;6582-6589.
54. + T cells. Nat. Med. 5:1999;1039-1043.
55. Ploegh H.L. Viral strategies of immune evasion. Science. 280:1998;248-253.
56. Leong C.C.et al. Modulation of natural killer cell cytotoxicity in human cytomegalovirus infection: the role of endogenous class I major histocompatibility complex and a viral class I homolog. J. Exp. Med. 187:1998;1681-1687.
57. Michelson S.et al. Modulation of RANTES production by human cytomegalovirus infection of fibroblasts. J. Virol. 71:1997;6495-6500.
58. Bodaghi B.et al. Chemokine sequestration by viral chemoreceptors as a novel viral escape strategy: withdrawal of chemokines from the environment of cytomegalovirus-infected cells. J. Exp. Med. 188:1998;855-866.
59. Chee M.S.et al. Human cytomegalovirus encodes three G protein-coupled receptor homologues. Nature. 344:1990;774-777.
60. Neote K.et al. Molecular cloning, functional expression and signaling characteristics of a CC chemokine receptor. Cell. 72:1993;415-425.
61. Gao J.L., Murphy P.M. Human cytomegalovirus open reading frame US28 encodes a functional β chemokine receptor. J. Biol. Chem. 269:1994;28539-28542.
62. Vieira J.et al. Functional analysis of the human cytomegalovirus US28 gene by insertion mutagenesis with the green fluorescent protein gene. J. Virol. 72:1998;8158-8165.
63. Kuhn D.E.et al. The cytomegalovirus US28 protein binds multiple CC chemokines with high affinity. Biochem. Biophys. Res. Commun. 211:1995;325-330.
64. Hirsch A.J., Shenk T. Human cytomegalovirus inhibits transcription of the CC chemokine MCP-1 gene. J. Virol. 73:1999;404-410.
65. Scholz M.et al. Cytomegalovirus- and interferon-related effects on human endothelial cells. Cytomegalovirus infection reduces upregulation of HLA class II antigen expression after treatment with interferon-γ Hum. Immunol. 35:1992;230-238.
66. Sedmak D.D.et al. Divergent patterns of ELAM-1, ICAM-1 and VCAM-1 expression on cytomegalovirus-infected endothelial cells. Transplantation. 58:1994;1379-1385.
67. Craigen J.L., Grundy J.E. Cytomegalovirus-induced upregulation of LFA-3 (CD58) and ICAM-1 (CD54) is a direct viral effect that is not prevented by ganciclovir or foscarnet treatment. Transplantation. 62:1996;1102-1108.
68. Burns L.J.et al. Intercellular adhesion molecule-1 expression in endothelial cells is activated by cytomegalovirus immediate early proteins. Transplantation. 67:1999;137-144.
69. Almeida G.D.et al. Human cytomegalovirus alters interleukin-6 production by endothelial cells. Blood. 83:1994;370-376.
70. Almeida-Porada G.et al. Altered production of GM-CSF and IL-8 in cytomegalovirus-infected, IL-1-primed umbilical cord endothelial cells. Exp. Hematol. 25:1997;1278-1285.
71. Murayama T.et al. Human cytomegalovirus induces interleukin-8 production by a human monocytic cell line, THP-1, through acting concurrently on AP-1- and NF-κB-binding sites of the interleukin-8 gene. J. Virol. 71:1997;5692-5695.
72. Murayama T.et al. Enhancement of human cytomegalovirus replication in a human lung fibroblast cell line by interleukin-8. J. Virol. 68:1994;7582-7585.
73. Penfold M.E.et al. Cytomegalovirus encodes a potent α chemokine. Proc. Natl. Acad. Sci. U. S. A. 96:1999;9839-9844.